Naringin Exhibits in vivo Prokinetic Activity via Activation of Ghrelin Receptor in Gastrointestinal Motility Dysfunction Rats
- 28 September 2013
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 92 (3-4), 191-197
- https://doi.org/10.1159/000354579
Abstract
Poncirus fructus (PF), also known as the dried immature fruit of Poncirus trifoliata (L.) Raf., has long been used as a cure for the treatment of various gastrointestinal disorders in eastern Asia. Recently, it was reported that naringin, a flavonoid constituent of the PF extract, causes the activation of ghrelin receptor in vitro. Although the ghrelin receptor is involved in the enhancement of intestinal motility, there are no studies as yet involving in vivo action of naringin. Therefore, the purpose of the present study is to investigate whether naringin exhibits a prokinetic effect in vivo. We measured the intestinal transit rate in rats with gastrointestinal motility dysfunction (GMD) and performed a pharmacokinetic analysis of naringin to investigate the effect of naringin on prokinetic activity in vivo. The results of this study show that the aqueous extract of PF and its constituent naringin have a strong prokinetic activity in GMD rats via activation of the ghrelin receptor. Surprisingly, pharmacokinetic analysis revealed that naringin has low bioavailability (11%), implying that the prokinetic effect of naringin was largely due to the local activation of ghrelin receptor in the intestine rather than a systemic effect after absorption. Indeed, it turned out that intravenous administration of naringin led to a lower prokinetic effect than when administrated orally to rats, indicating that naringin prefers to act on the intestinal wall rather than getting absorbed into the systemic circuit. This local mode of action might be advantageous for preventing possible systemic side effects since naringin is not well absorbed into the system circuit. Naringin exhibits an in vivo prokinetic activity by a preferable local activation of ghrelin receptor. Moreover, we propose that naringin could play a role as a leading compound for the development of ghrelin receptor-based prokinetic agents.Keywords
This publication has 29 references indexed in Scilit:
- Bioavailability enhancers of herbal origin: An overviewAsian Pacific Journal of Tropical Biomedicine, 2013
- Motilin and ghrelin as prokinetic drug targetsPharmacology & Therapeutics, 2009
- Effect of Grapefruit Juice, Naringin, Naringenin, and Bergamottin on the Intestinal Carrier-Mediated Transport of Talinolol in RatsJournal of Agricultural and Food Chemistry, 2008
- Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expressionCarcinogenesis: Integrative Cancer Research, 2008
- Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesisWorld Journal of Gastroenterology, 2008
- Ghrelin improves burn-induced delayed gastrointestinal transit in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Potential of ghrelin as a therapeutic approach for gastrointestinal motility disordersCurrent Opinion in Pharmacology, 2006
- Naringin Time-Dependently Lowers Hepatic Cholesterol Biosynthesis and Plasma Cholesterol in Rats Fed High-Fat and High-Cholesterol DietJournal of Medicinal Food, 2006
- A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokineticsAlimentary Pharmacology & Therapeutics, 2004